|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | Indiana University |
|---|---|
| Collaborator: |
National Institute on Aging (NIA) |
| Information provided by (Responsible Party): | Indiana University |
| ClinicalTrials.gov Identifier: | NCT00064870 |
Purpose
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
| Condition |
|---|
|
Alzheimer Disease Late Onset Alzheimer Disease Dementia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Alzheimer's Disease Genetics Study |
blood samples
| Estimated Enrollment: | 3000 |
| Study Start Date: | June 2002 |
| Estimated Study Completion Date: | September 2016 |
| Estimated Primary Completion Date: | September 2016 (Final data collection date for primary outcome measure) |
The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from families with multiple members diagnosed with AD. Qualifying families will have two living blood-related individuals who have been diagnosed with or are showing symptoms of AD or dementia. Local study sites are located all over the United States, and arrangements may be made for eligible families who do not live near a participating site. The biological samples and data from these families will be made available to qualified researchers, who must sign a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study participants before receiving DNA and data.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Families with two or more members with Alzheimer's disease or dementia
Inclusion Criteria:
Biological samples available
Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.
Exclusion Criteria:
Contacts and Locations| Contact: Study Coordinator | 1-800-526-2839 | alzstudy@iupui.edu |
| United States, Indiana | |
| Participants are being recruited from all over the United States | Recruiting |
| Nationwide, Indiana, United States | |
| Contact: NCRAD Study Coordinator 800-526-2839 alzstudy@iupui.edu | |
| Principal Investigator: | Tatiana M. Foroud, PhD | National Cell Repository for Alzheimer's Disease (NCRAD), Indiana University |
More Information
| Responsible Party: | Indiana University |
| ClinicalTrials.gov Identifier: | NCT00064870 History of Changes |
| Other Study ID Numbers: | IA0042, U24AG021886, NIH grant U24 AG21886 |
| Study First Received: | July 14, 2003 |
| Last Updated: | September 22, 2011 |
| Health Authority: | United States: Federal Government |
|
Alzheimer disease Late Onset Alzheimer disease risk factor genes Genetics Initiative Dementia |
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
